AXOGEN INC (AXGN) Stock News
NASDAQ:AXGN - Nasdaq - US05463X1063 - Common Stock - Currency: USD
AXGN Latest News, Press Relases and Analysis
These stocks are moving in today's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top gainers and losers in today's after hours session.
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
ALACHUA, Fla. and TAMPA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for AxoGen (AXGN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline
SOLV's first-quarter earnings showcase strong segmental performance. However, declining margins raise concerns.
MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off
McKesson's fourth-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
Why Jumia Technologies Stock Soared Today
Jumia reported a decline in revenue, but sales of physical goods grew. Jumia has faced a number of challenges, but profitability would be a major accomplishment. Shares of Jumia Technologies (NYSE: JMIA) were surging today after the African e-commerce company reported solid growth in orders, despite a decline in revenue, and guided to full-year profitability in 2027.
AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates
AxoGen (AXGN) delivered earnings and revenue surprises of -100% and 0.61%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: STXS
Axogen, Inc. Reports 2025 First Quarter Financial Results
Axogen, Inc. Reports 2025 First Quarter Financial Results
ALACHUA, Fla. and TAMPA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen Announces Chief Financial Officer Transition
Lindsey Hartley, CPA, appointed as Chief Financial Officer to succeed Nir Naor
COR Q2 Earnings & Revenues Beat Estimates, '25 EPS Guidance Raised
COR's second-quarter fiscal 2025 results showcase a strong segmental performance. The company's earnings guidance for fiscal 2025 looks encouraging.
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
ALACHUA and TAMPA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical...
Intuitive Surgical, Inc. (NASDAQ:ISRG): Among the Best Robotics Stocks to Buy According to Billionaires
We recently published a list of the 10 Best Robotics Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Intuitive Surgical, Inc. (NASDAQ:ISRG) stands against the other robotics stocks held by billionaires. Robotics Market Outlook The robotics industry has grown modestly over the past few years. […]
Axogen, Inc. To Host Analyst & Investor Day on March 4th
ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen, Inc. To Host Analyst & Investor Day on March 4th
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Craig Swandal, experienced medical device manufacturing executive, joins leadership team
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Craig Swandal, experienced medical device manufacturing executive, joins leadership team...
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
ALACHUA, Fla. and TAMPA, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
ALACHUA, Fla. and TAMPA, Fla., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative...